Angelo Zinellu Selected Research

cysteinylglycine (Cys-Gly)

5/2020	Systemic transsulfuration pathway thiol concentrations in chronic obstructive pulmonary disease patients.
7/2010	Plasma thiols and taurine levels in central retinal vein occlusion.
1/2010	Decreased plasma cysteinylglycine and taurine levels in branch retinal vein occlusion.
1/2010	Increased low-density lipoprotein S-homocysteinylation in chronic kidney disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Angelo Zinellu Research Topics

Disease

32	Inflammation (Inflammations) 01/2024 - 01/2013
22	Chronic Obstructive Pulmonary Disease (COPD) 07/2023 - 01/2016
20	Atherosclerosis 01/2024 - 03/2004
19	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 03/2004
19	COVID-19 06/2023 - 01/2020
15	Rheumatoid Arthritis 01/2024 - 04/2004
14	Neoplasms (Cancer) 02/2024 - 12/2010
7	Idiopathic Pulmonary Fibrosis 02/2024 - 01/2018
7	Chronic Renal Insufficiency 09/2016 - 01/2010
5	Hypoxia (Hypoxemia) 06/2023 - 03/2021
5	Hyperhomocysteinemia 03/2017 - 11/2006
5	Retinal Vein Occlusion 10/2012 - 09/2006
4	Asthma (Bronchial Asthma) 08/2023 - 11/2013
4	Rheumatic Diseases (Rheumatism) 01/2023 - 01/2017
4	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 12/2010
4	Prostatic Neoplasms (Prostate Cancer) 11/2022 - 08/2017
4	Macular Degeneration (Age-Related Maculopathy) 02/2020 - 01/2016
4	Glucosephosphate Dehydrogenase Deficiency 01/2019 - 06/2007
3	Ischemia 02/2024 - 12/2022
3	Hyperglycemia 04/2023 - 08/2010
3	Vascular Diseases (Vascular Disease) 11/2019 - 11/2006
3	Autoimmune Diseases (Autoimmune Disease) 03/2018 - 01/2017
3	Myocardial Infarction 01/2017 - 01/2010
3	Atherosclerotic Plaque (Atheroma) 01/2014 - 06/2009
3	Hypercholesterolemia 12/2013 - 09/2009
2	Disease Progression 04/2024 - 01/2023
2	Schizophrenia (Dementia Praecox) 12/2023 - 07/2023
2	Dementia (Dementias) 12/2023 - 11/2019
2	Obstructive Sleep Apnea 05/2023 - 06/2021
2	Critical Illness (Critically Ill) 04/2023 - 01/2022
2	Pulmonary Hypertension 12/2022 - 06/2022
2	Stroke (Strokes) 01/2022 - 01/2017
2	Hypertension (High Blood Pressure) 01/2022 - 01/2021
2	Cystinuria 09/2021 - 04/2004
2	Anastomotic Leak 09/2021 - 01/2018
2	Malnutrition (Nutritional Deficiencies) 01/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

50	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2013
20	HomocysteineIBA 07/2023 - 03/2004
18	AntioxidantsIBA 08/2023 - 10/2012
14	Sulfhydryl Compounds (Thiols)IBA 11/2020 - 03/2004
13	Arginine (L-Arginine)FDA Link 03/2024 - 11/2013
12	Cysteine (L-Cysteine)FDA Link 01/2023 - 03/2004
10	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 03/2024 - 01/2008
8	Taurine FDA Link 10/2020 - 06/2009
7	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2023 - 08/2017
7	Glutathione (Reduced Glutathione)IBA 03/2021 - 01/2010
7	Proteins (Proteins, Gene)FDA Link 05/2020 - 08/2007
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2024 - 11/2019
6	Aryldialkylphosphatase (Paraoxonase)IBA 08/2023 - 01/2016
6	C-Reactive ProteinIBA 01/2023 - 01/2018
6	AlbuminsIBA 07/2022 - 01/2014
6	LipidsIBA 01/2021 - 06/2009
5	Methotrexate (Mexate)FDA LinkGeneric 01/2023 - 01/2017
5	KynurenineIBA 01/2023 - 09/2016
5	Tryptophan (L-Tryptophan)FDA Link 01/2023 - 09/2016
5	MicroRNAs (MicroRNA)IBA 11/2022 - 11/2015
5	Malondialdehyde (Propanedial)IBA 06/2021 - 09/2016
5	CholesterolIBA 01/2021 - 04/2008
5	Nitric Oxide Synthase (NO Synthase)IBA 01/2019 - 12/2007
4	OrnithineIBA 03/2024 - 09/2021
4	CitrullineIBA 03/2024 - 09/2014
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 06/2023 - 01/2021
4	PolyaminesIBA 12/2022 - 01/2021
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2022 - 09/2014
4	Thiobarbituric Acid Reactive SubstancesIBA 10/2020 - 01/2016
4	cysteinylglycine (Cys-Gly)IBA 05/2020 - 01/2010
4	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2019 - 06/2007
4	oxidized low density lipoproteinIBA 01/2015 - 11/2006
3	arylesteraseIBA 07/2023 - 11/2022
3	Alanine Transaminase (SGPT)IBA 06/2023 - 01/2021
3	HomoarginineIBA 04/2023 - 11/2019
3	CytokinesIBA 03/2021 - 01/2017
3	Blood Proteins (Serum Proteins)IBA 10/2020 - 01/2016
3	Amino Acids FDA Link 01/2019 - 01/2010
2	symmetric dimethylarginineIBA 03/2024 - 01/2016
2	ischemia-modified albuminIBA 02/2024 - 01/2024
2	ErbB Receptors (EGF Receptor)IBA 02/2024 - 12/2010
2	Cell Adhesion MoleculesIBA 01/2024 - 12/2023
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2024 - 01/2023
2	Antipsychotic Agents (Antipsychotics)IBA 12/2023 - 12/2023
2	dimethylarginineIBA 12/2023 - 01/2023
2	AllantoinIBA 08/2023 - 09/2016
2	Uric Acid (Urate)IBA 08/2023 - 09/2016
2	Glucose (Dextrose)FDA LinkGeneric 04/2023 - 04/2008
2	nintedanibIBA 01/2023 - 10/2020
2	NeopterinIBA 01/2023 - 12/2017
2	Methionine (L-Methionine)FDA Link 01/2023 - 06/2009
2	EnzymesIBA 11/2022 - 01/2016
2	MB Form Creatine KinaseIBA 01/2022 - 09/2021
2	CreatinineIBA 01/2022 - 01/2016
2	ErgothioneineIBA 09/2021 - 02/2016
2	fibrin fragment D (D-dimer)IBA 09/2021 - 01/2020
2	Serum AlbuminIBA 08/2021 - 01/2021
2	Oxidants (Oxidizing Agents)IBA 04/2021 - 01/2020
2	Complement System Proteins (Complement)IBA 01/2021 - 01/2018

Therapy/Procedure

13	Therapeutics 04/2024 - 12/2010
3	Artificial Respiration (Mechanical Ventilation) 12/2022 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2024 - 01/2021
2	Immunotherapy 01/2024 - 01/2021
2	Critical Care (Surgical Intensive Care) 11/2022 - 08/2022